Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-22 | 2020-11-26 | 126909 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2021-01-22 | 2021-05-06 | 132276 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86927 |
| ACT RANITIDINE | 300MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3320 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94846 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94849 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94852 |
| ACT RANITIDINE | 300MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94855 |
| ACT RANITIDINE | 150MG | TABLET | Resolved | 2020-01-24 | 2020-05-14 | 104307 |
| ACT REPAGLINIDE | 0.5MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149591 |
| ACT REPAGLINIDE | 1MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149596 |
| ACT REPAGLINIDE | 2MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149606 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2019-09-05 | 2019-10-17 | 93169 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-05-09 | 2025-04-28 | 227492 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-07-04 | 2025-04-28 | 232235 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2020-05-29 | 2020-06-04 | 116135 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2017-05-24 | 2017-09-19 | 10988 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-10-17 | 2020-04-02 | 96714 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-01-30 | 2020-06-11 | 104908 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-05-01 | 2020-08-17 | 113779 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| TEVA-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255821 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
| TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117529 |
| TEVA-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117526 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
| TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |